Recombinant Human Anti-TG x Human Anti-TPO Bispecific Antibody (Tandem scFv-Fc) (BSFVF-H351)

Recombinant Anti-TG x Anti-TPO Bispecific Antibody (Tandem scFv-Fc) is designed to be expressed as a homodimer, which has 2+2 antigen-binding valency. This format consists of one Fc region and two tandem scFv fragments, in which the anti-TG/TPO tandem scFv is fused to the Fc domain. The engineered fragment format is used to extend the half-life. This BsAb can bind two antigens simultaneously and block the synthesis of thyroid hormones. It is designed for the research of Autoimmune thyroid disease therapy.

Datasheet INQUIRY

Specifications

Targets

TG & TPO

Type

Constant Domain-extended Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Autoimmune thyroid disease

Targets

Target 1

Gene ID

7038

UniProt ID

P01266

Alternative Names

AITD3, TG; thyroglobulin; TGN

Target 2

TPO

Gene ID

7173

UniProt ID

P07202

Alternative Names

MSA; TPX; TDH2A; TPPO; thrombopoietin; megakaryocyte growth and development factor; MGDF

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-TG x Human Anti-TPO Bispecific Antibody (Tandem scFv-Fc) (BSFVF-H351). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-TG x Human Anti-TPO Bispecific Antibody (Tandem scFv-Fc) (CAT#: BSFVF-H351)

Specifications

Targets

Customer Reviews and Q&As